Sebastian Schlaweck
Bonn, NW 53127, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Inhibition of Fibroblast Growth Factor Receptor 3 Signaling by Ponatinib Reduces Growth and Cytokine Production of Multiple Myeloma Cells.
Journal: International journal of molecular sciences
Published: May 13, 2026
The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic Cells.
Journal: Cancers
Published: September 30, 2024
Pacritinib protects dendritic cells more efficiently than ruxolitinib.
Journal: Experimental hematology
Published: May 17, 2021
Elotuzumab spares dendritic cell integrity and functionality.
Journal: Journal of cancer research and clinical oncology
Published: January 28, 2021
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient.
Journal: Annals of hematology
Published: December 09, 2020
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells.
Journal: Cancer immunology, immunotherapy : CII
Published: September 22, 2020
Exanthem subitum (human herpesvirus-6 reactivation) after autologous stem cell transplantation.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: November 22, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026